Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$951M |
| 2 |
Advanced Micro Devices
AMD
|
+$589M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$418M |
| 4 |
Lam Research
LRCX
|
+$412M |
| 5 |
Microsoft
MSFT
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$585M |
| 3 |
STMP
Stamps.com, Inc.
STMP
|
+$111M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$87.8M |
| 5 |
TSMC
TSM
|
+$70.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.05% |
| 2 | Financials | 11.79% |
| 3 | Healthcare | 10.9% |
| 4 | Consumer Discretionary | 10.36% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Lowe's Companies
LOW
$122B
| $16.4M | 0.01% |
80,912
+2,040
| +3% | +$407K |
|
302
NOV
NOV
$7.09B
| $16.1M | 0.01% |
1,228,589
-1,183
| -0.1% | -$16K |
|
303
Amgen
AMGN
$219B
| $16.1M | 0.01% |
75,511
-2,413
| -3% | -$555K |
|
304
Diamondback Energy
FANG
$53.1B
| $15.8M | 0.01% |
167,371
-7,401
| -4% | -$595K |
|
|
PXD
305
DELISTED
Pioneer Natural Resource Co.
PXD
| $15.7M | 0.01% |
94,424
-3,956
| -4% | -$599K |
|
306
Piper Sandler
PIPR
$5.02B
| $15.3M | 0.01% |
443,328
+50,292
| +13% | +$1.68M |
|
307
Simpson Manufacturing
SSD
$7.96B
| $15.1M | 0.01% |
140,966
+211
| +0.1% | +$23.4K |
|
308
Berkshire Hathaway Class B
BRK.B
$1.13T
| $14.8M | 0.01% |
54,285
-3,925
| -7% | -$1.1M |
|
309
ResMed
RMD
$32.4B
| $14.7M | 0.01% |
55,763
+11,234
| +25% | +$3.07M |
|
310
Owens Corning
OC
$12.1B
| $14.4M | 0.01% |
167,872
-335
| -0.2% | -$31.5K |
|
311
Alarm.com
ALRM
$2.78B
| $14.1M | 0.01% |
180,738
+3,227
| +2% | +$267K |
|
|
NSTG
312
DELISTED
NanoString Technologies, Inc.
NSTG
| $14.1M | 0.01% |
292,917
+30,782
| +12% | +$1.77M |
|
313
Advanced Energy
AEIS
$13B
| $13.7M | 0.01% |
156,238
+9,554
| +7% | +$894K |
|
|
NEX
314
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $13.5M | 0.01% |
2,943,606
-53,499
| -2% | -$215K |
|
|
INVX
315
Innovex International
INVX
$2.15B
| $13.4M | 0.01% |
533,575
-131,596
| -20% | -$3.5M |
|
316
BJ's Restaurants
BJRI
$1.49B
| $13.3M | 0.01% |
317,968
-10,617
| -3% | -$446K |
|
317
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.29B
| $13.1M | 0.01% |
475,488
+39,426
| +9% | +$1.1M |
|
318
Ecopetrol
EC
$35.8B
| $13.1M | 0.01% |
911,029
| – | – |
|
319
iShares Global Healthcare ETF
IXJ
$4.14B
| $13M | 0.01% |
155,497
-433
| -0.3% | -$37.5K |
|
320
United Parcel Service
UPS
$87.7B
| $12.8M | 0.01% |
70,246
+10,349
| +17% | +$2.04M |
|
321
Idexx Laboratories
IDXX
$46.5B
| $12.7M | 0.01% |
20,493
+829
| +4% | +$557K |
|
322
Cavco Industries
CVCO
$4.45B
| $12.6M | 0.01% |
53,229
+2,960
| +6% | +$712K |
|
323
Moog Inc Class A
MOG.A
$13B
| $12.5M | 0.01% |
163,513
+5,930
| +4% | +$463K |
|
324
Equinor
EQNR
$93.7B
| $12M | 0.01% |
470,478
+11,397
| +2% | +$244K |
|
325
Texas Capital Bancshares
TCBI
$4.32B
| $12M | 0.01% |
199,497
-5,512
| -3% | -$343K |
|
Similar funds
Ken Fisher's Q3 2021 Portfolio in Review
As of Q3 2021, Ken Fisher held 1,103 positions worth $161B, up 1.1% from $159B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q3 2021 filing shows 93 new, 444 increased, 375 reduced and 75 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M. The largest sale was Visa, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q3 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M.
- Ken Fisher added most to Meta Platforms (Facebook) in Q3 2021, an estimated $951M increase.
- Ken Fisher's biggest Q3 2021 reduction was Visa, cutting an estimated $1.24B.
- Ken Fisher fully exited Stamps.com, Inc. in Q3 2021, selling an estimated $111M.
- Ken Fisher's ten largest holdings make up 31% of its $161B portfolio in Q3 2021.
- Ken Fisher opened 93 new positions and closed 75 in Q3 2021.
- Ken Fisher's portfolio value rose 1.1% quarter-over-quarter to $161B.
Based on Fisher Asset Management's 13F filing for Q3 2021, filed 26 Oct 2021.